Tarek Sahmoud - Net Worth and Insider Trading
Tarek Sahmoud Net Worth
The estimated net worth of Tarek Sahmoud is at least $20,300 dollars as of 2024-05-22. Tarek Sahmoud is the Chief Medical Officer of Context Therapeutics Inc and owns about 10,000 shares of Context Therapeutics Inc (CNTX) stock worth over $20,300. Details can be seen in Tarek Sahmoud's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Tarek Sahmoud has not made any transactions after 2022-08-16 and currently still holds the listed stock(s).
Transaction Summary of Tarek Sahmoud
Tarek Sahmoud Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tarek Sahmoud owns 1 companies in total, including Context Therapeutics Inc (CNTX) .
Click here to see the complete history of Tarek Sahmoud’s form 4 insider trades.
Insider Ownership Summary of Tarek Sahmoud
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CNTX | Context Therapeutics Inc | 2022-08-16 | Chief Medical Officer |
Tarek Sahmoud Latest Holdings Summary
Tarek Sahmoud currently owns a total of 1 stock. Tarek Sahmoud owns 10,000 shares of Context Therapeutics Inc (CNTX) as of August 16, 2022, with a value of $20,300.
Latest Holdings of Tarek Sahmoud
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CNTX | Context Therapeutics Inc | 2022-08-16 | 10,000 | 2.03 | 20,300 |
Holding Weightings of Tarek Sahmoud
Tarek Sahmoud Form 4 Trading Tracker
According to the SEC Form 4 filings, Tarek Sahmoud has made a total of 1 transactions in Context Therapeutics Inc (CNTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Context Therapeutics Inc is the acquisition of 10,000 shares on August 16, 2022, which cost Tarek Sahmoud around $19,500.
Insider Trading History of Tarek Sahmoud
- 1
Tarek Sahmoud Trading Performance
GuruFocus tracks the stock performance after each of Tarek Sahmoud's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tarek Sahmoud is -37.5%. GuruFocus also compares Tarek Sahmoud's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tarek Sahmoud within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Tarek Sahmoud's insider trading performs compared to the benchmark.
Performance of Tarek Sahmoud
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -24.48 | | | | | |
| Relative Return to S&P 500(%) | -14.45 | | | | | |
Tarek Sahmoud Ownership Network
Tarek Sahmoud Owned Company Details
What does Context Therapeutics Inc do?
Who are the key executives at Context Therapeutics Inc?
Tarek Sahmoud is the Chief Medical Officer of Context Therapeutics Inc. Other key executives at Context Therapeutics Inc include director & Chief Executive Officer Martin A. Lehr , Chief Financial Officer Jennifer Lynn Minai-azary , and Chief Legal Officer & Corp. Sec Alex C. Levit .
Context Therapeutics Inc (CNTX) Insider Trades Summary
Over the past 18 months, Tarek Sahmoud made no insider transaction in Context Therapeutics Inc (CNTX). Other recent insider transactions involving Context Therapeutics Inc (CNTX) include a net purchase of 57,118 shares made by Martin A. Lehr , a net purchase of 25,000 shares made by Jennifer Lynn Minai-azary , and a net purchase of 6,000 shares made by Alex C. Levit .
In summary, during the past 3 months, insiders sold 0 shares of Context Therapeutics Inc (CNTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Context Therapeutics Inc (CNTX) were sold and 88,118 shares were bought by its insiders, resulting in a net purchase of 88,118 shares.
Context Therapeutics Inc (CNTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Context Therapeutics Inc Insider Transactions
Tarek Sahmoud Mailing Address
Above is the net worth, insider trading, and ownership report for Tarek Sahmoud. You might contact Tarek Sahmoud via mailing address: 3675 Market Street, Suite 200, Philadelphia Pa 19104.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
